Previous Close | 1.7000 |
Open | 1.7000 |
Bid | 0.0000 |
Ask | 2.5000 |
Strike | 20.00 |
Expire Date | 2024-09-20 |
Day's Range | 1.7000 - 1.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 44 |
Passive investing in index funds can generate returns that roughly match the overall market. But one can do better than...
Oral presentations include additional comparative data between EscharEx® and SANTYL®, and new analyses show strong correlation between wound bed preparation and wound healing Analyses validate the planned design and endpoints of the upcoming Phase III study YAVNE, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, announced today that recent clinical data from EscharEx® Phase II studies will be
MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.